📊 Score Breakdown
Offering Ability
100
Cash Runway
65
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
40%
💰 Capital Raise
53%
• Under 12 months cash (9mo)
• Active shelf registration ($250M, 10271% of market cap)
🔄 Reverse Split
40%
• 50-day avg $1.65 approaching $1 threshold
• 9 months cash with weak price
📉 Score Deterioration
10%
• Score in HIGH risk zone (66/100)
💹 Market Data
Market Cap$2.43M
Shares Outstanding4.46M
Float4.46M
Cash$9.54M
Debt$1.32M
Short InterestN/A
🏛 Institutional Holdings
8 institutional holders · 20.2K shares
#1
DRW Securities, LLC
9.6K shares
#2
Anson Funds Management LP
6.5K shares
#3
Vanguard Group Inc
3.2K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest99.7K
Days to Cover1.0
% of Float2.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
424B5
ATM
May 01, 2026
8-K
8K EVENT
May 01, 2026
EFFECT
EFFECT
Apr 10, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XXII
📊 XXII FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XXII Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.